The serum-based CCA (Figure 6; neuroblastomas) did not have the high levels of non-ALT-specific CCA signal that we found previously in the whole-blood-based CCA (osteosarcomas) [14], which is consistent with the non-ALT-specific signal from whole-blood being present in the blood cells. The gene discussed is GPT; the disease is osteosarcoma.